Go Pro

Docusign's (DOCU) "Market Outperform" Rating Reiterated at Citizens Jmp

Docusign logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Citizens JMP reiterated its “Market Outperform” rating on DocuSign and set an $86 price target, implying 28.41% upside from the prior close.
  • Analyst sentiment remains mixed: DocuSign has a consensus “Hold” rating and an average price target of $63.67, despite some bullish targets as high as $86.
  • DocuSign recently beat quarterly expectations, reporting $1.16 EPS and $875.75 million in revenue, with revenue up 9.4% year over year.
  • Interested in Docusign? Here are five stocks we like better.

Docusign (NASDAQ:DOCU - Get Free Report)'s stock had its "market outperform" rating reissued by stock analysts at Citizens Jmp in a research note issued on Friday, Benzinga reports. They presently have a $86.00 price target on the stock. Citizens Jmp's price target suggests a potential upside of 28.41% from the company's previous close.

DOCU has been the subject of several other reports. Robert W. Baird set a $72.00 price target on Docusign in a research report on Friday. Piper Sandler reiterated a "neutral" rating and issued a $75.00 price objective on shares of Docusign in a research note on Friday. Needham & Company LLC reaffirmed a "hold" rating on shares of Docusign in a research report on Friday. Evercore set a $65.00 target price on Docusign in a report on Friday. Finally, UBS Group set a $60.00 price target on Docusign in a report on Friday, June 5th. Three research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Docusign has a consensus rating of "Hold" and a consensus price target of $63.67.

Read Our Latest Analysis on DOCU

Docusign Price Performance

Docusign stock opened at $66.97 on Friday. The firm has a 50 day simple moving average of $55.24 and a 200-day simple moving average of $49.74. The stock has a market cap of $12.79 billion, a price-to-earnings ratio of 44.58, a price-to-earnings-growth ratio of 2.32 and a beta of 0.90. Docusign has a 1-year low of $40.16 and a 1-year high of $86.65.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.09 by $0.07. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The firm had revenue of $875.75 million during the quarter, compared to the consensus estimate of $867.22 million. During the same period last year, the company earned $0.30 EPS. The company's quarterly revenue was up 9.4% on a year-over-year basis. Equities analysts expect that Docusign will post 2.03 earnings per share for the current fiscal year.

Insider Buying and Selling at Docusign

In related news, insider Robert Chatwani sold 15,902 shares of the firm's stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $43.01, for a total transaction of $683,945.02. Following the transaction, the insider owned 72,805 shares of the company's stock, valued at $3,131,343.05. This trade represents a 17.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider James P. Shaughnessy sold 12,000 shares of the company's stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the sale, the insider directly owned 52,815 shares of the company's stock, valued at approximately $2,405,195.10. This represents a 18.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 90,602 shares of company stock valued at $4,323,749. 0.59% of the stock is owned by company insiders.

Hedge Funds Weigh In On Docusign

Hedge funds and other institutional investors have recently bought and sold shares of the company. Modus Advisors LLC acquired a new stake in shares of Docusign in the 4th quarter worth $27,000. Cary Street Partners Investment Advisory LLC grew its holdings in Docusign by 309.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company's stock worth $38,000 after acquiring an additional 424 shares during the period. Basepoint Wealth LLC purchased a new position in Docusign in the fourth quarter worth $39,000. WealthCollab LLC lifted its holdings in Docusign by 372.4% in the first quarter. WealthCollab LLC now owns 855 shares of the company's stock valued at $41,000 after acquiring an additional 674 shares during the period. Finally, Virtus Advisers LLC purchased a new stake in shares of Docusign during the 2nd quarter worth $47,000. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Quarterly results beat expectations: Fiscal Q2 revenue rose 9.4% year over year to $875.7 million, exceeding the $867.2 million consensus estimate. Adjusted EPS of $1.16 also topped expectations of approximately $1.08–$1.09, compared with $0.92 a year earlier. Docusign Announces Second Quarter Fiscal 2027 Financial Results
  • Positive Sentiment: Raised full-year outlook: Docusign increased fiscal 2027 guidance for revenue, annual recurring revenue (ARR), and IAM’s share of total ARR. Full-year revenue guidance of approximately $3.5 billion was broadly in line with consensus, while third-quarter revenue guidance of $886 million–$890 million was near analysts’ $888.2 million estimate. Docusign Raises Full-Year Forecast on AI Momentum
  • Positive Sentiment: AI growth narrative is gaining traction: Management cited accelerating IAM adoption and AI-related demand as drivers of the improved outlook. Docusign also plans to make its Model Context Protocol server available to every AI agent on September 30, positioning its agreement technology as an infrastructure layer for enterprise AI workflows. Docusign Agreement Layer for the Agentic Enterprise Coming to Every Agent
  • Positive Sentiment: Analyst price-target support: BTIG raised its Docusign price target to $75, while Morgan Stanley also boosted its target, adding to the bullish reaction following the earnings report. BTIG Boosts Docusign Price Target
  • Neutral Sentiment: Mixed technical and analyst signals: DOCU has formed a bullish “golden cross” and trades well above its 200-day moving average, but Needham reaffirmed a “hold” rating, indicating that some analysts believe the recent rally may already reflect much of the improved outlook.

About Docusign

(Get Free Report)

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Featured Stories

Analyst Recommendations for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines